Literature DB >> 7693610

Foveal cone ERGs in fellow eyes of patients with unilateral neovascular age-related macular degeneration.

M A Sandberg1, S Miller, A R Gaudio.   

Abstract

PURPOSE: To determine whether fellow eyes with normal visual acuity of patients with unilateral neovascular age-related macular degeneration (AMD) have retinal malfunction.
METHODS: Foveal cone electroretinograms (ERGs) were recorded from fellow eyes with visual acuities of 20/25 or better of 73 patients with unilateral neovascular AMD and from 28 normal volunteers of comparable age. Responses were elicited with a 4 degrees stimulus flickering at 42 Hz presented by a stimulator-ophthalmoscope.
RESULTS: The study eyes of the patients were found to have foveal cone ERGs that, on average, were normal in amplitude but delayed in implicit (peak) time after adjustment of the data for age, sex, iris pigmentation, and refractive error by multiple linear regression. Based on all subjects, amplitude declined with increasing age and was smaller in eyes with darker irides; implicit time increased with increasing age.
CONCLUSIONS: These findings suggest that fellow eyes with normal visual acuity of patients with unilateral neovascular AMD tend to have foveal cones that are normal in number but that function abnormally. In addition, foveal cone ERG amplitude should be adjusted for both age and iris pigmentation and implicit time should be adjusted for age when assessing retinal function of elderly patients.

Entities:  

Mesh:

Year:  1993        PMID: 7693610

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  10 in total

Review 1.  The electroretinogram: a useful tool for evaluating age-related macular disease?

Authors:  Emma J Berrow; Hannah E Bartlett; Frank Eperjesi; Jonathan M Gibson
Journal:  Doc Ophthalmol       Date:  2010-03-16       Impact factor: 2.379

2.  Cone-mediated multifocal electroretinogram in age-related macular degeneration: progression over a long-term follow-up.

Authors:  Christina Gerth; Peter B Delahunt; Suhail Alam; Lawrence S Morse; John S Werner
Journal:  Arch Ophthalmol       Date:  2006-03

Review 3.  Diagnosis and classification of macular degenerations: an approach based on retinal function testing.

Authors:  L Scullica; B Falsini
Journal:  Doc Ophthalmol       Date:  2001-05       Impact factor: 2.379

4.  Reduced amplitude and delayed latency in foveal response of multifocal electroretinogram in early age related macular degeneration.

Authors:  J Li; M O Tso; T T Lam
Journal:  Br J Ophthalmol       Date:  2001-03       Impact factor: 4.638

5.  Foveal electroretinograms and choroidal perfusion characteristics in fellow eyes of patients with unilateral neovascular age-related macular degeneration.

Authors:  J F Remulla; A R Gaudio; S Miller; M A Sandberg
Journal:  Br J Ophthalmol       Date:  1995-06       Impact factor: 4.638

6.  Assessment of multifocal electroretinogram abnormalities and their relation to morphologic characteristics in patients with large drusen.

Authors:  Christina Gerth; David Hauser; Peter B Delahunt; Lawrence S Morse; John S Werner
Journal:  Arch Ophthalmol       Date:  2003-10

7.  The role of the ERG in the diagnosis and treatment of Age-Related Macular Degeneration.

Authors:  Christina Gerth
Journal:  Doc Ophthalmol       Date:  2008-06-07       Impact factor: 2.379

8.  Quantitative analysis of cone photoreceptor distribution and its relationship with axial length, age, and early age-related macular degeneration.

Authors:  Ryo Obata; Yasuo Yanagi
Journal:  PLoS One       Date:  2014-03-14       Impact factor: 3.240

9.  Detection of early age-related macular degeneration using novel functional parameters of the focal cone electroretinogram.

Authors:  Ashley Wood; Thomas Margrain; Alison Mary Binns
Journal:  PLoS One       Date:  2014-05-05       Impact factor: 3.240

10.  Predicting vision gains with anti-VEGF therapy in neovascular age-related macular degeneration patients by using low-luminance vision.

Authors:  Ronald E P Frenkel; Howard Shapiro; Ivaylo Stoilov
Journal:  Br J Ophthalmol       Date:  2015-11-05       Impact factor: 4.638

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.